About the work
Despite a strong correlation to severity of AD pathology, the measurement of medial temporal lobe atrophy (MTA) is not being widely used in daily clinical practice as a criterion in the diagnosis of prodromal and probable AD. This is mainly because the methods available to date are sophisticated and difficult to implement for routine use in most hospitals -volumetric methods- or lack objectivity -visual rating scales-. In this pilot study we aim to describe a new, simple and objective method for measuring the rate of MTA in relation to the global atrophy using clinically available neuroimaging and describe the rationale behind this method.
Description:
This method consists of calculating a ratio with the area of 3 regions traced manually on one single coronal MRI slide at the level of the interpeduncular fossa: 1. the medial temporal lobe region (A); 2. the parenchima within the medial temporal region, that includes the hippocampus and the parahippocampal gyrus -the fimbria taenia and plexus choroideus are excluded- (B); and 3. the body of the ipsilateral lateral ventricle (C). Therefrom we can compute the ratio “Medial Temporal Atrophy index” at both sides as follows: MTAi = (A-B) x10 / C
Conclusions:
The MTAi is a simple 2D-method for measuring the relative extent of atrophy in the MTL in relation to the global brain atrophy. This method can be useful for a more accurate diagnosis of AD in routine clinical practice. Further studies are needed to assess the usefulness of MTAi in the diagnosis of early AD, in tracking the progression of AD and in the differential diagnosis of AD with other dementias.
Print work information
Work information
Title MTA index: a simple 2D-method for assessing atrophy of the medial temporal lobe using clinically available neuroimaging
Despite a strong correlation to severity of AD pathology, the measurement of medial temporal lobe atrophy (MTA) is not being widely used in daily clinical practice as a criterion in the diagnosis of prodromal and probable AD. This is mainly because the methods available to date are sophisticated and difficult to implement for routine use in most hospitals -volumetric methods- or lack objectivity -visual rating scales-. In this pilot study we aim to describe a new, simple and objective method for measuring the rate of MTA in relation to the global atrophy using clinically available neuroimaging and describe the rationale behind this method.
Description:
This method consists of calculating a ratio with the area of 3 regions traced manually on one single coronal MRI slide at the level of the interpeduncular fossa: 1. the medial temporal lobe region (A); 2. the parenchima within the medial temporal region, that includes the hippocampus and the parahippocampal gyrus -the fimbria taenia and plexus choroideus are excluded- (B); and 3. the body of the ipsilateral lateral ventricle (C). Therefrom we can compute the ratio “Medial Temporal Atrophy index” at both sides as follows: MTAi = (A-B) x10 / C
Conclusions:
The MTAi is a simple 2D-method for measuring the relative extent of atrophy in the MTL in relation to the global brain atrophy. This method can be useful for a more accurate diagnosis of AD in routine clinical practice. Further studies are needed to assess the usefulness of MTAi in the diagnosis of early AD, in tracking the progression of AD and in the differential diagnosis of AD with other dementias.
Work type Technical
Tags morphometry, mild cognitive impairment, alzheimer, mta index, neuroimaging
-------------------------
Registry info in Safe Creative
Identifier 1311099180863
Entry date Nov 9, 2013, 3:58 PM UTC
License All rights reserved
-------------------------
Copyright registered declarations
Author. Holder Manuel Menendez Gonzalez. Date Nov 9, 2013.
Information available at https://www.safecreative.org/work/1311099180863-mta-index-a-simple-2d-method-for-assessing-atrophy-of-the-medial-temporal-lobe-using-clinically-available-neuroimaging
/
Registration: 1311099180863
